| Literature DB >> 27258386 |
Nicole G Ertl1,2, Wayne A O'Connor1,3, Alexie Papanicolaou4, Aaron N Wiegand1, Abigail Elizur1.
Abstract
BACKGROUND: Oysters have important ecological functions in their natural environment, acting as global carbon sinks and improving water quality by removing excess nutrients from the water column. During their life-time oysters are exposed to a variety of pathogens that can cause severe mortality in a range of oyster species. Environmental stressors encountered in their habitat can increase the susceptibility of oysters to these pathogens and in general have been shown to impact on oyster immunity, making immune parameters expressed in these marine animals an important research topic.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27258386 PMCID: PMC4892480 DOI: 10.1371/journal.pone.0156649
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of S. glomerata assembly, ORF prediction and CEGMA analysis.
| Strand-specific transcriptome | Combined transcriptome | |
|---|---|---|
| 519,639 | 502,645 | |
| N50 length (bp) | 949 | 1,238 |
| Mean transcript length (bp) | 633 | 701 |
| Min transcript length (bp) | 201 | 201 |
| Max transcript length (bp) | 27,590 | 30,775 |
| 414,578 | 453,096 | |
| N50 length (bp) | 768 | 937 |
| Mean transcript length (bp) | 564 | 613 |
| Min transcript length (bp) | 201 | 201 |
| Max transcript length (bp) | 27,590 | 30,775 |
| 292,626 | 318,450 | |
| 72,056 | 73,425 | |
| 49,896 | 61,221 | |
| 85,786 | 108,130 | |
| Min length (bp) | 300 | 300 |
| Max length (bp) | 25,917 | 29,883 |
| Complete proteins (%) | 95.56 | 91.94 |
| Partial proteins (%) | 99.19 | 95.56 |
Fig 1Transcript patterns across six different S. glomerata tissues.
A) non-normalised and non-strand specific tissue reads were mapped to the combined reference transcriptome and b) strand-specific and normalised tissue reads were mapped to the strand-specific reference transcriptome, using CLC Workbench version 7.5. Graph shows the number of transcripts that are common across individual tissue patterns, with 1 standing for “transcript present in tissue” and 0 for “transcript not present in tissue”. The order in which the tissues are listed is as follows: haemolymph (closest to the x-axis label), gill, mantle, muscle, gonad and digestive. The respective top graphs show the full-scale graph, with the respective lower graphs emphasising the fine scale features of the same graph by adding a graph break.
Potential S. glomerata immune and immune related ORFs determined by GO and/or InterProScan annotation.
| # of ORFs | Details | |
|---|---|---|
| peptidoglycan recognition proteins (PGRPs) | 23 | |
| gram-negative bacteria binding proteins (GNBPs) | 3 | |
| Collectins | 53 | |
| Ficolins | 30 | |
| c-type lectins | 110 | |
| macrophage mannose receptors | 237 | |
| scavenger receptors (SRs) | 26 | based on domain information in [ |
| thioester-containing proteins (TEPs) | 31 | |
| fibrinogen-related proteins (FREPs) | 40 | |
| down syndrome cell adhesion molecule (DSCAM) | 11 | |
| Galectins | 20 | |
| Toll-like receptors (TLRs) | 220 | |
| interferon-induced helicase c domain-containing protein 1 (MDA5)/(also RIG-I called) DDX58 | 22 | |
| stabilin-2 | 3 | |
| myeloid differentiation primary response protein 88 (MyD88) | 14 | |
| sterile alpha and TIR domain containing protein (SARM1) | 3 | |
| IL-1R-associated kinase (IRAK) | 1 | |
| tumor necrosis factor [TNF] receptor-associated factor (TRAF) | 31 | TRAF7 (8), TRAF6 (3), TRAF2 (3), TRAF4 (3), TRAF3 (1), TRAF6-like isoform 1 (1) |
| inhibitor of nuclear factor kappa-b kinase (IKK) | 6 | |
| transforming-growth-factor [TGF]-β-activated kinase 1 (TAK1, also called MEKK7) | 6 | |
| TAK1-binding protein (TAB1) | 3 | |
| TAK1-binding protein 2 (TAB2) | 2 | |
| nuclear factor [NF]-κB essential modulator (NEMO) | 2 | |
| TRAF-family-member-associated NF-κB activator-binding kinase 1 (TBK1) | 13 | |
| inhibitor of nuclear factor-κB (IκB) | 4 | |
| nuclear factor of kappa light polypeptide gene enhancer in b-cells 2, p49/p100 (NFκB2) | 2 | |
| activator protein 1 (AP-1) | 1 | |
| interferon regulatory factor (IRF) | 7 | |
| janus activated kinase (JAK) | 2 | |
| signal transducer and activator of transcription (STAT) | 4 | |
| mitogen-activated protein kinases (MAPK) | 13 | MAPK3 (1), MAPK14 (4), MAPK15 (2), MAPK6 (3) and MAPK7 (1) |
| mitogen-activated protein kinase kinase (MEK also called MKK) | 11 | |
| mitogen-activated protein kinase kinase kinase (MAP3K or MEKK) | 34 | MEKK1 (2), MEKK19 (8), MEKK2 (1), MEKK10 (1), MEKK15 (1), MEKK9 (1), MEKK13 (2) |
| mitogen-activated protein kinase kinase kinase MLT-like isoform 1 (also called ZAK isoform 1) | 1 | |
| mitogen-activated protein kinase kinase kinase kinase (MAP4K) | 10 | MAP4K3 (6) and MAP4K5 (4) |
| receptor-interacting protein 1 (RIP1) | 3 | |
| Pellino | 2 | |
| toll-interacting protein (TOLLIP) | 1 | |
| suppressor of cytokine signaling (SOCS) | 5 | |
| NF-kappa-B inhibitor-like protein 1 (NFKBIL1) | 1 | |
| interleukin-1 receptor-associated kinase 1-binding protein 1 (IRAK1BP1) | 1 | |
| mitochondrial antiviral-signaling protein (MAVS) | 1 | |
| nuclear factor of activated T-cells (NFAT) | 1 | |
| c-jun-amino terminal kinase-interacting protein 4 (JIP4) | 12 | |
| c-jun-amino terminal kinase-interacting protein 1 (JIP1) | 1 | |
| fibrinogen (α/β/γ-chain) | 8 | |
| heat shock protein [Hsp]20 family | 13 | |
| Hsp70 family | 40 | |
| Hsp90 family | 25 | |
| Hsp60 | 2 | |
| Hsp10 | 1 | |
| stress-induced-phosphoprotein 1 (STIP1) | 2 | |
| intraflagellar transport protein 25 homolog (Hspb11) | 2 | |
| HIF-1α / HIF-2α | 6 | |
| HIF-1β | 2 | |
| hypoxia-inducible factor 1-α inhibitor (HIF1AN) | 1 | |
| prolyl hydorxylases (PHD) | 2 | |
| p300 / CREB-binding protein (CBP) | 13 | |
| superoxide dismutase (SOD) | 25 | with mitochondrial manganese-SOD domains (4) and copper/zinc-SOD domains (21) |
| catalase (CAT) | 7 | |
| glutathione peroxidase (GPX) | 7 | |
| nitric oxide synthase (NOS) | 2 | |
| Thioredoxin | 6 | |
| thioredoxin reductase | 4 | |
| Peroxiredoxin | 11 | |
| Glutaredoxin | 6 | |
| glutathione S-transferase (GST) | 53 | |
| glutathione synthase (GS) | 2 | |
| glutamate—cysteine ligase regulatory subunit | 1 | |
| glutamate—cysteine ligase catalytic subunit | 3 | |
| methionine sulfoxide reductase A | 3 | |
| methionine-R-sulfoxide reductase B3 | 4 | |
| glutathione reductase (mitochondrial) | 1 | |
| NADPH oxidase (NOX) | 4 | |
| p67phox | 1 | |
| cytochrome b-245 heavy chain-like (gp91phox) | 1 | |
| cytochrome b-245 light chain-like (p22phox) | 1 | |
| dual oxidase (DUOX) | 7 | |
| small GTPase Rac | 2 | |
| evolutionarily conserved signaling intermediate in toll pathways, mitochondrial (ECSIT) | 1 | |
| Cathepsin | 59 | cathepsin B (9), F (3), L (17), C (1), O (2), Z (1), D (3) |
| Lysozymes | 16 | |
| big defensins | 5 | |
| Hydramacin | 1 | |
| bactericidal permeability increasing protein (BPI) | 27 | |
| macrophage migration inhibitory factor (MIF) | 3 | |
| interleukin [IL]-17 | 3 | |
| interleukin-17 receptor d | 5 | |
| interleukin-6 receptor | 12 | |
| Septin | 7 | |
| c4b-binding protein alpha/beta chain | 8 | |
| FAS-associated death domain protein (FADD) | 3 | |
| TNF receptor superfamily members | 9 | |
| TNF superfamily members | 8 | |
| apoptosis-inducing factor 1, mitochondrial (AIF) | 1 | |
| Bax | 2 | |
| Caspases | 114 | |
| baculoviral IAP repeat-containing proteins (IAPs) | 75 | |
| direct IAP-binding protein of low isoelectric point (DIABLO) | 4 | |
| interferon alpha-inducible protein 27 (IFI27) | 25 |
Fig 2Schematic of the predicted innate immune processes of S. glomerata.
S. glomerata innate immune transcripts observed in this study are predicted to be involved in a range of different innate immune processes, (components regulating the different pathways are not visualised in this figure). Abbreviations are as follows: PPRs (pattern recognition receptors), TLR (Toll-like receptor), PAMPs (pathogen-associated molecular patterns), DAMPs (damage-associated molecular patterns), TRAF (tumor necrosis factor receptor-associated factor), TAK1 (transforming-growth-factor-β-activated kinase 1), ROS (reactive oxygen species), ECSIT (evolutionary conserved signalling intermediate in toll pathways), RIG-1/MDA5 (interferon-induced helicase c domain-containing protein 1), MAVS (mitochondrial antiviral-signalling protein), AIF (apoptosis-inducing factor 1), AP-1 (activator protein 1), NF-κB (nuclear factor kappa B), IRF (interferon regulatory factor), HIF (hypoxia-inducible factor), CBP (CREB-binding protein), RNI (reactive nitrogen intermediates), AMP (antimicrobial peptide). ↑ arrows used in the figure (excluding the ones used in the nucleus) depict signalling pathways.